EMA’s transformative treatments of 2020
In this article, we summarise the trial findings for the European Medicines Agency’s 13 most transformative therapies of 2020.
List view / Grid view
In this article, we summarise the trial findings for the European Medicines Agency’s 13 most transformative therapies of 2020.
Following approval by Emisphere shareholders, Novo Nordisk will acquire the company for a total of $1.8 billion.
The EMA’s human medicines committee (CHMP) recommended fifteen medicines for various approvals at its January 2020 meeting; with ten drugs receiving marketing authorisation recommendations and five receiving positive opinions for specific treatments.